Cargando…

Increased Dead Space Ventilation and Refractory Hypercapnia in Patients With Coronavirus Disease 2019: A Potential Marker of Thrombosis in the Pulmonary Vasculature

OBJECTIVES: Mortality rates in intubated coronavirus disease 2019 patients remain markedly elevated. Some patients develop sudden refractory hypercapnia and hypoxemia not explained by worsening pulmonary parenchymal disease. This case series highlights clinical findings and management of coronavirus...

Descripción completa

Detalles Bibliográficos
Autores principales: Oppenheimer, Beno W., Bakker, Jan, Goldring, Roberta M., Teter, Katherine, Green, David L., Berger, Kenneth I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7515611/
https://www.ncbi.nlm.nih.gov/pubmed/33063042
http://dx.doi.org/10.1097/CCE.0000000000000208
_version_ 1783586841439502336
author Oppenheimer, Beno W.
Bakker, Jan
Goldring, Roberta M.
Teter, Katherine
Green, David L.
Berger, Kenneth I.
author_facet Oppenheimer, Beno W.
Bakker, Jan
Goldring, Roberta M.
Teter, Katherine
Green, David L.
Berger, Kenneth I.
author_sort Oppenheimer, Beno W.
collection PubMed
description OBJECTIVES: Mortality rates in intubated coronavirus disease 2019 patients remain markedly elevated. Some patients develop sudden refractory hypercapnia and hypoxemia not explained by worsening pulmonary parenchymal disease. This case series highlights clinical findings and management of coronavirus disease 2019 patients with refractory hypercapnia despite maximal/optimal ventilatory support. Hypercapnia could not be explained by worsening lung disease or other common factors, and thus, a pulmonary vascular etiology was suggested. The pillars of management were targeted to improve pulmonary vascular patency via aggressive anticoagulation and support right ventricular function. DATA SOURCES: Four consecutive patients with confirmed coronavirus disease 2019 infection with sudden hypercapnia and hypoxemia were included. DATA SYNTHESIS: There was sequential development of: 1) severe hypercapnia attributable to marked elevation of dead space without radiographic changes; 2) concomitant coagulopathy manifest by an increase in d-dimer levels; 3) progressive shunt with consequent hypoxemia; and 4) right ventricular dysfunction. Management included extracorporeal Co(2) removal, direct thrombin inhibition, pulmonary vasodilators, and inotropic support. Marked improvement in Pao(2) allowed reduction in Fio(2) in all patients, extracorporeal Co(2) removal was discontinued in three patients over the ensuing 3 weeks, and one patient was discharged home. CONCLUSIONS: We speculate that thromboinflammation with pulmonary microvasculature occlusion leads to a sudden increase in dead space and shunt resulting in severe hypercapnia and hypoxemia in coronavirus disease 2019 patients. Early identification of these physiologic and clinical biomarkers could trigger the institution of therapies aiming to reverse the hypercoagulable state and support right ventricular function.
format Online
Article
Text
id pubmed-7515611
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-75156112020-10-14 Increased Dead Space Ventilation and Refractory Hypercapnia in Patients With Coronavirus Disease 2019: A Potential Marker of Thrombosis in the Pulmonary Vasculature Oppenheimer, Beno W. Bakker, Jan Goldring, Roberta M. Teter, Katherine Green, David L. Berger, Kenneth I. Crit Care Explor Case Report OBJECTIVES: Mortality rates in intubated coronavirus disease 2019 patients remain markedly elevated. Some patients develop sudden refractory hypercapnia and hypoxemia not explained by worsening pulmonary parenchymal disease. This case series highlights clinical findings and management of coronavirus disease 2019 patients with refractory hypercapnia despite maximal/optimal ventilatory support. Hypercapnia could not be explained by worsening lung disease or other common factors, and thus, a pulmonary vascular etiology was suggested. The pillars of management were targeted to improve pulmonary vascular patency via aggressive anticoagulation and support right ventricular function. DATA SOURCES: Four consecutive patients with confirmed coronavirus disease 2019 infection with sudden hypercapnia and hypoxemia were included. DATA SYNTHESIS: There was sequential development of: 1) severe hypercapnia attributable to marked elevation of dead space without radiographic changes; 2) concomitant coagulopathy manifest by an increase in d-dimer levels; 3) progressive shunt with consequent hypoxemia; and 4) right ventricular dysfunction. Management included extracorporeal Co(2) removal, direct thrombin inhibition, pulmonary vasodilators, and inotropic support. Marked improvement in Pao(2) allowed reduction in Fio(2) in all patients, extracorporeal Co(2) removal was discontinued in three patients over the ensuing 3 weeks, and one patient was discharged home. CONCLUSIONS: We speculate that thromboinflammation with pulmonary microvasculature occlusion leads to a sudden increase in dead space and shunt resulting in severe hypercapnia and hypoxemia in coronavirus disease 2019 patients. Early identification of these physiologic and clinical biomarkers could trigger the institution of therapies aiming to reverse the hypercoagulable state and support right ventricular function. Lippincott Williams & Wilkins 2020-09-17 /pmc/articles/PMC7515611/ /pubmed/33063042 http://dx.doi.org/10.1097/CCE.0000000000000208 Text en Copyright © 2020 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of the Society of Critical Care Medicine. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.
spellingShingle Case Report
Oppenheimer, Beno W.
Bakker, Jan
Goldring, Roberta M.
Teter, Katherine
Green, David L.
Berger, Kenneth I.
Increased Dead Space Ventilation and Refractory Hypercapnia in Patients With Coronavirus Disease 2019: A Potential Marker of Thrombosis in the Pulmonary Vasculature
title Increased Dead Space Ventilation and Refractory Hypercapnia in Patients With Coronavirus Disease 2019: A Potential Marker of Thrombosis in the Pulmonary Vasculature
title_full Increased Dead Space Ventilation and Refractory Hypercapnia in Patients With Coronavirus Disease 2019: A Potential Marker of Thrombosis in the Pulmonary Vasculature
title_fullStr Increased Dead Space Ventilation and Refractory Hypercapnia in Patients With Coronavirus Disease 2019: A Potential Marker of Thrombosis in the Pulmonary Vasculature
title_full_unstemmed Increased Dead Space Ventilation and Refractory Hypercapnia in Patients With Coronavirus Disease 2019: A Potential Marker of Thrombosis in the Pulmonary Vasculature
title_short Increased Dead Space Ventilation and Refractory Hypercapnia in Patients With Coronavirus Disease 2019: A Potential Marker of Thrombosis in the Pulmonary Vasculature
title_sort increased dead space ventilation and refractory hypercapnia in patients with coronavirus disease 2019: a potential marker of thrombosis in the pulmonary vasculature
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7515611/
https://www.ncbi.nlm.nih.gov/pubmed/33063042
http://dx.doi.org/10.1097/CCE.0000000000000208
work_keys_str_mv AT oppenheimerbenow increaseddeadspaceventilationandrefractoryhypercapniainpatientswithcoronavirusdisease2019apotentialmarkerofthrombosisinthepulmonaryvasculature
AT bakkerjan increaseddeadspaceventilationandrefractoryhypercapniainpatientswithcoronavirusdisease2019apotentialmarkerofthrombosisinthepulmonaryvasculature
AT goldringrobertam increaseddeadspaceventilationandrefractoryhypercapniainpatientswithcoronavirusdisease2019apotentialmarkerofthrombosisinthepulmonaryvasculature
AT teterkatherine increaseddeadspaceventilationandrefractoryhypercapniainpatientswithcoronavirusdisease2019apotentialmarkerofthrombosisinthepulmonaryvasculature
AT greendavidl increaseddeadspaceventilationandrefractoryhypercapniainpatientswithcoronavirusdisease2019apotentialmarkerofthrombosisinthepulmonaryvasculature
AT bergerkennethi increaseddeadspaceventilationandrefractoryhypercapniainpatientswithcoronavirusdisease2019apotentialmarkerofthrombosisinthepulmonaryvasculature